AR and prostate carcinoma: In both androgen-dependent and castration-resistant prostate cancer cells, β-arr1 enhances the binding of androgen receptor (AR) to androgen response elements, favoring cell proliferation, growth, and invasion, as well as in vivo tumor formation, local invasion, and distant metastasis (Purayil et al., 2015).